| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| AMGN GSK AZN STWD GNL CLNY | 2015-12 | Purchase | 2020-12 | 31,627 | 34,270 | 0 | 31,627 | 0 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ABR+A | AT COST | 20,580 | 20,449 |
| AGR | AT COST | 17,872 | 20,225 |
| AMGN | AT COST | 16,067 | 27,088 |
| ARI | AT COST | 28,562 | 18,448 |
| AZN | AT COST | 14,348 | 23,745 |
| BGS | AT COST | 24,877 | 26,206 |
| BKCC | AT COST | 20,299 | 7,323 |
| BMXT | AT COST | 25,025 | 22,776 |
| BP | AT COST | 24,754 | 14,486 |
| CODI+A | AT COST | 20,130 | 23,152 |
| CVX | AT COST | 21,094 | 19,348 |
| EQNR | AT COST | 21,796 | 20,525 |
| FTAI+A | AT COST | 19,923 | 22,519 |
| GNL | AT COST | 32,452 | 25,958 |
| GOGL | AT COST | 21,008 | 17,656 |
| GSBD | AT COST | 22,979 | 21,988 |
| GSK | AT COST | 26,379 | 24,496 |
| IVR+A | AT COST | 20,371 | 20,112 |
| LMRK | AT COST | 28,184 | 18,038 |
| LUMN (f/k/a CTL) | AT COST | 31,363 | 14,379 |
| MIC | AT COST | 36,830 | 23,144 |
| MLPDX | AT COST | 25,390 | 9,357 |
| OPI (f/k/a GOV) | AT COST | 45,482 | 19,626 |
| PSEC | AT COST | 32,211 | 21,813 |
| PUK+ | AT COST | 23,402 | 25,767 |
| RDSA | AT COST | 20,243 | 14,407 |
| STWD | AT COST | 28,687 | 24,572 |
| T | AT COST | 24,299 | 19,533 |
| VZ | AT COST | 22,190 | 27,178 |
| WFC+L | AT COST | 20,013 | 23,766 |
| CLNY | AT COST | 0 | 0 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Office expenses | 872 | 872 | 0 | 0 |
| Name | Address |
|---|---|
| Luis E San Miguel |
7745 SW 78th St Miami,FL33143 |